Clostridium difficile-associated colitis. Part 2: Therapy and prevention

被引:0
|
作者
Markus, P. M. [1 ]
机构
[1] Elisabeth Krankenhaus Essen Contilia GmbH, Akad Lehrkrankenhaus, Klin Allgemein Viszeral & Unfallchirurg, Klara Kopp Weg 1, D-45138 Essen, Germany
关键词
Pseudomembranous colitis; Clostridium difficile toxin A; Clostridium difficile toxin B Metronidazole; Vancomycin;
D O I
10.1007/s00053-012-0316-2
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Clostridium difficile is an anaerobic, Gram positive, spore-forming and toxin-producing bacillus. Colonization of the intestinal tract is facilitated by the administration of various antibiotics, in particular clindamycin, broad spectrum penicillins, fluorochinlones and cephalosporins. The clinical manifestations of C. difficile infections range from an asymptomatic carrier to fulminant disease with toxic megacolon. The cardinal clinical symptom is watery diarrhea accompanied by a pronounced leucocytosis. The most important initial step in the treatment of C. difficile - associated colitis is cessation of the responsible antibiotic. Treatment of non-severe C. difficile infection consists of oral metronidazole and patients with severe C. difficile - associated colitis are treated with oral vancomycin. The recurrence rate is high and a distinction must be made between a true reinfection with a different strain and a relapse of persistent diarrhea.
引用
收藏
页码:447 / 453
页数:7
相关论文
共 50 条
  • [31] Clostridium difficile-associated diarrhea
    Bujanda, Luis
    Cosme, Angel
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2009, 32 (01): : 48 - 56
  • [32] Clostridium Difficile-Associated Pouchitis
    Bo Shen
    John R. Goldblum
    Tracy L. Hull
    Feza H. Remzi
    Ana E. Bennett
    Victor W. Fazio
    Digestive Diseases and Sciences, 2006, 51 : 2361 - 2364
  • [33] Clostridium difficile-associated diarrhoea
    Wight, N
    Curtis, H
    Hyde, J
    Borriello, SP
    Mahida, YR
    POSTGRADUATE MEDICAL JOURNAL, 1998, 74 (877) : 677 - 678
  • [34] Clostridium difficile-associated Pouchitis
    Shen, Bo
    Goldblum, John R.
    Hull, Tracy L.
    Remzi, Feza H.
    Bennett, Ana E.
    Fazio, Victor W.
    DIGESTIVE DISEASES AND SCIENCES, 2006, 51 (12) : 2361 - 2364
  • [35] PROBIOTICS FOR THE PREVENTION OF CLOSTRIDIUM DIFFICILE-ASSOCIATED DIARRHEA IN ADULTS AND CHILDREN
    Gaines, Chloe
    Moore, Jerrel
    GASTROENTEROLOGY NURSING, 2019, 42 (03) : 299 - 301
  • [36] The mechanisms and efficacy of probiotics in the prevention of Clostridium difficile-associated diarrhoea
    Parkes, Gareth C.
    Sanderson, Jeremy D.
    Whelan, Kevin
    LANCET INFECTIOUS DISEASES, 2009, 9 (04): : 237 - 244
  • [37] Clostridium difficile-associated diarrhea
    Schroeder, MS
    AMERICAN FAMILY PHYSICIAN, 2005, 71 (05) : 921 - 928
  • [38] Clostridium difficile-associated colitis (vol 50, pg 1536, 2004)
    Hull, MW
    Beck, PL
    CANADIAN FAMILY PHYSICIAN, 2005, 51 : 192 - 192
  • [39] Clostridium difficile-associated diarrhea and colitis -: Clinical manifestations, diagnosis and treatment
    Cleary, RK
    DISEASES OF THE COLON & RECTUM, 1998, 41 (11) : 1435 - 1449
  • [40] Clostridium difficile-associated colitis. Part 1: Epidemiology, clinical manifestation and diagnosis [Clostridium-difficileassoziierte Kolitis. Teil 1: Epidemiologie, klinisches Erscheinungsbild und Diagnose]
    Markus P.M.
    coloproctology, 2012, 34 (5) : 379 - 390